RxDoctor Payments Data

Daniel Hsia

Pediatric Endocrinology · Atlanta, GANPI 1417140997

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,950 of the $6,394 with a category attached, or 77.4%. Eli Lilly accounts for 99.7% of it on its own, with 1 other manufacturer making up the rest.

$6,394in general payments, 2019–2025

Across 10 payments — averaging $639.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$6K
  • Insulet Corporation$21
$1,814,449in research payments, 2019–2025

Across 1,681 payments — averaging $1079.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$798K
  • Eli Lilly$429K
  • Novo Nordisk AS$332K
  • Vivus LLC$126K
  • Takeda Pharmaceuticals U.S.A., Inc.$79K
  • Janssen Research & Development, LLC$32K
  • plus $19K from 1 others

What the payments were for

  • Consulting fees$4,95077%
  • Travel & lodging$1,05617%
  • Food & beverage$3886%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly9$6,373
Insulet Corporation1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,394 in reported general payments places this provider in the 75th percentile of 30 pediatric endocrinology providers in Georgia.

See all pediatric endocrinology providers in Georgia →

Other pediatric endocrinology in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →